141 related articles for article (PubMed ID: 12577096)
1. Oligodendroglioma: clinical profile and treatment results.
Jacob R; Jyothirmayi R; Dalal Y; Nambiar U; Rajan B; Nair MK
Neurol India; 2002 Dec; 50(4):462-6. PubMed ID: 12577096
[TBL] [Abstract][Full Text] [Related]
2. Oligodendroglioma: does deferring treatment compromise outcome?
Feigenberg SJ; Amdur RJ; Morris CG; Mendenhall WM; Marcus RB; Friedman WA
Am J Clin Oncol; 2003 Jun; 26(3):e60-6. PubMed ID: 12796617
[TBL] [Abstract][Full Text] [Related]
3. [Long-term results of treatment in patients with oligodendrogliomas and oligoastrocytomas of the cerebral hemispheres].
Iun'pén V; Oliushin VE; Ulitin AIu; Maslova LN; Petrov AA
Zh Vopr Neirokhir Im N N Burdenko; 2008; (2):6-10; discussion 10-1. PubMed ID: 18720725
[TBL] [Abstract][Full Text] [Related]
4. Treatment of oligodendroglioma: an update.
Paleologos NA; Cairncross JG
Neuro Oncol; 1999 Jan; 1(1):61-8. PubMed ID: 11550303
[TBL] [Abstract][Full Text] [Related]
5. Combined treatment modality for anaplastic oligodendroglioma and oligoastrocytoma: a 10-year update of a phase II study.
Jeremic B; Milicic B; Grujicic D; Samardzic M; Antunovic V; Dagovic A; Aleksandrovic J
Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):509-14. PubMed ID: 15145170
[TBL] [Abstract][Full Text] [Related]
6. Glioblastoma multiforme with oligodendroglial component (GBMO): favorable outcome after post-operative radiotherapy and chemotherapy with nimustine (ACNU) and teniposide (VM26).
Vordermark D; Ruprecht K; Rieckmann P; Roggendorf W; Vince GH; Warmuth-Metz M; Kölbl O; Flentje M
BMC Cancer; 2006 Oct; 6():247. PubMed ID: 17049083
[TBL] [Abstract][Full Text] [Related]
7. [Results in oligodendroglioma: postoperative radiotherapy combined with chemotherapy].
Kitahara M; Katakura R; Mashiyama S; Niizuma H; Yoshimoto T; Suzuki J; Mori T; Wada T
No Shinkei Geka; 1987 Apr; 15(4):397-403. PubMed ID: 3614532
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and feasibility of procarbazine, ranimustine and vincristine chemotherapy, and the role of surgical resection in anaplastic oligodendroglioma.
Yamamoto M; Iwaasa M; Nonaka M; Tsugu H; Nabeshima K; Fukushima T
Anticancer Res; 2005; 25(6A):3715-23. PubMed ID: 16302731
[TBL] [Abstract][Full Text] [Related]
9. Impact of surgery, chemotherapy and irradiation on long term outcome of intracranial malignant non-germinomatous germ cell tumors: results of the German Cooperative Trial MAKEI 89.
Calaminus G; Bamberg M; Jürgens H; Kortmann RD; Sörensen N; Wiestler OD; Göbel U
Klin Padiatr; 2004; 216(3):141-9. PubMed ID: 15175958
[TBL] [Abstract][Full Text] [Related]
10. [Results of multimodal treatment of patients with glial tumors of cerebral hemispheres].
Cheremisin VM; Gaĭdar BV; Asaturian MA; Korobkova IM; Trufanov GE; Anosov NA
Vestn Rentgenol Radiol; 1995; (4):13-5. PubMed ID: 8571528
[TBL] [Abstract][Full Text] [Related]
11. Perfusion magnetic resonance imaging predicts patient outcome as an adjunct to histopathology: a second reference standard in the surgical and nonsurgical treatment of low-grade gliomas.
Law M; Oh S; Johnson G; Babb JS; Zagzag D; Golfinos J; Kelly PJ
Neurosurgery; 2006 Jun; 58(6):1099-107; discussion 1099-107. PubMed ID: 16723889
[TBL] [Abstract][Full Text] [Related]
12. Treatment of oligodendrogliomas with or without postoperative irradiation.
Wallner KE; Gonzales M; Sheline GE
J Neurosurg; 1988 May; 68(5):684-8. PubMed ID: 3357029
[TBL] [Abstract][Full Text] [Related]
13. Combined surgery, radiation, and chemotherapy for oligodendroglial gliomatosis cerebri.
Fukushima Y; Nakagawa H; Tamura M
Br J Neurosurg; 2004 Jun; 18(3):306-10. PubMed ID: 15327240
[TBL] [Abstract][Full Text] [Related]
14. Clear cell ependymoma: a clinicopathologic and radiographic analysis of 10 patients.
Fouladi M; Helton K; Dalton J; Gilger E; Gajjar A; Merchant T; Kun L; Newsham I; Burger P; Fuller C
Cancer; 2003 Nov; 98(10):2232-44. PubMed ID: 14601094
[TBL] [Abstract][Full Text] [Related]
15. Factors possibly influencing the prognosis of oligodendroglioma.
Sun ZM; Genka S; Shitara N; Akanuma A; Takakura K
Neurosurgery; 1988 May; 22(5):886-91. PubMed ID: 3380278
[TBL] [Abstract][Full Text] [Related]
16. Should radiotherapy for low-grade glioma be given immediately after surgery or at the time of progression?
Rosenfeld MR
Nat Clin Pract Neurol; 2006 Mar; 2(3):128-9. PubMed ID: 16932536
[No Abstract] [Full Text] [Related]
17. Postoperative radiotherapy and chemotherapy in the management of oligodendroglioma: single institutional review of 88 patients.
Ozyigit G; Onal C; Gurkaynak M; Soylemezoglu F; Zorlu F
J Neurooncol; 2005 Nov; 75(2):189-93. PubMed ID: 16132506
[TBL] [Abstract][Full Text] [Related]
18. 12 years' experience with intraoperative radiotherapy (IORT) of malignant gliomas.
Schueller P; Micke O; Palkovic S; Schroeder J; Moustakis C; Bruns F; Schuck A; Wassmann H; Willich N
Strahlenther Onkol; 2005 Aug; 181(8):500-6. PubMed ID: 16044217
[TBL] [Abstract][Full Text] [Related]
19. Fractionated stereotactic radiation therapy in the management of primary oligodendroglioma and oligoastrocytoma.
Combs SE; Schulz-Ertner D; Thilmann C; Edler L; Debus J
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):797-802. PubMed ID: 15936562
[TBL] [Abstract][Full Text] [Related]
20. [Oligodendroglioma. Clinical course in relation to histological grading].
Neumann J; Kimpel J; Gulotta F
Neurochirurgia (Stuttg); 1978 Mar; 21(2):35-42. PubMed ID: 643146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
